| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | rofecoxib | FAERS: 3 | OFFSIDES US FAERS | |
| 2 | Aripiprazole | FAERS: 2 | US FAERS | |
| 3 | Bosentan | FAERS: 2 | US FAERS | |
| 4 | Sunitinib | FAERS: 2 | OFFSIDES US FAERS | |
| 5 | Foscarnet | FAERS: 1 | US FAERS | |
| 6 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 7 | NuvaRing | FAERS: 1 | US FAERS | |
| 8 | Ortho Evra | FAERS: 1 | US FAERS | |
| 9 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 10 | Testosterone | FAERS: 1 | US FAERS | |
| 11 | apixaban | FAERS: 1 | US FAERS | |
| 12 | beyaz | FAERS: 1 | US FAERS | |
| 13 | etonogestrel | FAERS: 1 | US FAERS | |
| 14 | Ezetimibe | OFFSIDES | ||
| 15 | Metformin | OFFSIDES | ||
| 16 | Quinidine | OFFSIDES | ||
| 17 | Raloxifene Hydrochloride | OFFSIDES | ||
| 18 | Sunitinib | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.